<qa>  What is the name of the fusions of NTRK123, ROS1- Part D: Relapsed or refractory non-neuroblastoma, extracranial solid tumors with NTRK123, ROS1, or ALK gene fusions documented by a CLIA-approved lab prior to enrollment; 